Literature DB >> 34480673

Highly sialylated mucin-type glycopeptide from porcine intestinal mucosa after heparin extraction: O-glycan profiling and immunological activity evaluation.

Xin Zhang1, Chen Wang1, Qing Han1, Xuan Chen1, Guoyun Li2,3, Guangli Yu4,5.   

Abstract

Mucins are the major proteins that distributed on the intestinal mucosa layer and protect the intestine from pathogens infection. The composition of intestinal mucin O-glycans can affect the health of the gastrointestinal tract in pigs. Porcine intestinal mucosa is widely used as the main raw material of heparin extraction. The heparin extraction residues rich in mucins were usually wasted. The structure of mucin derived O-glycans in porcine intestinal mucosa are currently unknown. In this study, we isolated the mucins from the heparin extraction residues and profiled the O-glycans. After heparin extraction, mucin was digested with trypsin, and separated by strong anion exchange chromatography. The mucin derived O-glycans were release by alkaline β elimination, and analyzed by ultra high performance liquid chromatography-porous graphitized carbon-Fourier transform mass spectrometry (UPLC-PGC-FTMS/MS). Thirty five kinds of O-glycans were identified, most of which were Core 3-derived glycans. In particular, the O-glycans containing sialic acid Neu5Ac accounted for 71.93% of the total O-glycans, which were different from that of other species, including mouse intestine, fish intestine, and porcine colon. The high content sialylated mucin may explain its effect in biological processes. Furthermore, the immunological activity results indicated that the porcine intestinal mucin could promote phagocytosis and proliferation without any cytotoxic effects, which may aid in the development of immunomodulators.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Immunoregulatory; O-glycans; Porcine intestinal mucin; Sialic acid; Structural characterization

Mesh:

Substances:

Year:  2021        PMID: 34480673     DOI: 10.1007/s10719-021-10014-y

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  34 in total

Review 1.  Mucins in cancer: protection and control of the cell surface.

Authors:  Michael A Hollingsworth; Benjamin J Swanson
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

2.  MUC1 plays an essential role in tumor immunity of colorectal cancer stem cell vaccine.

Authors:  Mei Guo; Biao Luo; Meng Pan; Miao Li; Fengshu Zhao; Jun Dou
Journal:  Int Immunopharmacol       Date:  2020-05-26       Impact factor: 4.932

Review 3.  Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.

Authors:  Inka Brockhausen
Journal:  EMBO Rep       Date:  2006-06       Impact factor: 8.807

4.  Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.

Authors:  Catharina Steentoft; Sergey Y Vakhrushev; Hiren J Joshi; Yun Kong; Malene B Vester-Christensen; Katrine T-B G Schjoldager; Kirstine Lavrsen; Sally Dabelsteen; Nis B Pedersen; Lara Marcos-Silva; Ramneek Gupta; Eric Paul Bennett; Ulla Mandel; Søren Brunak; Hans H Wandall; Steven B Levery; Henrik Clausen
Journal:  EMBO J       Date:  2013-04-12       Impact factor: 11.598

Review 5.  Intestinal goblet cells and mucins in health and disease: recent insights and progress.

Authors:  Young S Kim; Samuel B Ho
Journal:  Curr Gastroenterol Rep       Date:  2010-10

6.  Glycan structures of ocular surface mucins in man, rabbit and dog display species differences.

Authors:  Louise Royle; Elizabeth Matthews; Anthony Corfield; Monica Berry; Pauline M Rudd; Raymond A Dwek; Stephen D Carrington
Journal:  Glycoconj J       Date:  2008-05-09       Impact factor: 2.916

7.  Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis.

Authors:  Sjoerd van der Post; Karolina S Jabbar; George Birchenough; Liisa Arike; Noreen Akhtar; Henrik Sjovall; Malin E V Johansson; Gunnar C Hansson
Journal:  Gut       Date:  2019-03-26       Impact factor: 23.059

8.  Proximal colon-derived O-glycosylated mucus encapsulates and modulates the microbiota.

Authors:  Kirk Bergstrom; Xindi Shan; David Casero; Albert Batushansky; Venu Lagishetty; Jonathan P Jacobs; Christopher Hoover; Yuji Kondo; Bojing Shao; Liang Gao; Wesley Zandberg; Benjamin Noyovitz; J Michael McDaniel; Deanna L Gibson; Sepideh Pakpour; Negin Kazemian; Samuel McGee; Courtney W Houchen; Chinthalapally V Rao; Timothy M Griffin; Justin L Sonnenburg; Rodger P McEver; Jonathan Braun; Lijun Xia
Journal:  Science       Date:  2020-10-23       Impact factor: 47.728

Review 9.  Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.

Authors:  Santosh Kumar Behera; Ardhendu Bhusan Praharaj; Budheswar Dehury; Sapna Negi
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 3.009

10.  Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.

Authors:  Malin E V Johansson; Jenny K Gustafsson; Jessica Holmén-Larsson; Karolina S Jabbar; Lijun Xia; Hua Xu; Fayez K Ghishan; Frederic A Carvalho; Andrew T Gewirtz; Henrik Sjövall; Gunnar C Hansson
Journal:  Gut       Date:  2013-02-20       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.